Symbiot™ stent delivery via 8 Fr guiding catheter from the right radial artery in an acute coronary syndrome due to a degenerating saphenous vein graft: A strategy for reducing access site complications

Journal of Invasive Cardiology

Volumn 17, Issue 2, 2005, Pages 96-97

  Banks, Matthew ^a   Patterson, Mark ^a   Kiemeneij, Ferdinand ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; CLOPIDOGREL; DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TIROFIBAN; VERAPAMIL;

AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CLINICAL EXAMINATION; CORONARY STENT; ELECTROCARDIOGRAPHY; GRAFT FAILURE; HEART CATHETER; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; RADIAL ARTERY; SAPHENOUS VEIN GRAFT; ACUTE DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; HEART LEFT VENTRICLE FUNCTION; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; SAPHENOUS VEIN; STENT; SYNDROME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; HEART CATHETERIZATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RADIAL ARTERY; SAPHENOUS VEIN; STENTS; SYNDROME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 28444444528     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Fragmin and Fast Revascularisation during Instability in Coronary artery disease Investigators. Invasive compared to non-invasive treatment in unstable coronary-artery disease: FRISCH prospective randomised multicentre study. Lancet 1999;354:704-715.
2. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Mb/IMa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
3. Laarman G, Muthasamy TS, Swart H, et al. Direct coronary stent implantation: Safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation. Cathet Cardiovasc Intervent 2001;52:443-448.
4. Kiemeniej F, Laarman GJ, Odekerken D, et al. A randomised comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The ACCESS study. J Am Coll Cardiol 1997;29:1269-1275.
5. Saito S, Tanaka S, Hiroe Yet al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: Results of the test for myocardial infarction by prospective unicenter randomisation for access sites (TEMPURA) trial. Cathet Cardiovasc Intervent 2003;59:26-33.
6. Laarman GJ, Kiemeneij F, Guagliaumi G, et al. Safety and preliminary efficacy of a novel ePTFE covered selfexpandable stent in saphenous vein graft lesions: The Symbiot II Trial. (Submitted to J Am Coll Cardiol).